Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
PDE6C Blocking Peptide (AC1189)
Cat.#: ACPP-1189
Specifications
Despition PDE6C Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1177 Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) 50 µg inquiry ACPP-1278 EAAT1 Blocking Peptide (AC1278) 250 µg inquiry ACPP-1380 Human LECT2 Protein (AC1380) 2 µg inquiry ACPP-1323 FYN Blocking Peptide (AC1323) 250 µg inquiry ACPP-1118 Human Insulin (Active) (AC1118) 25 mg inquiry ACPP-1217 P2Y2 Blocking Peptide (AC1217) 250 µg inquiry ACPP-1767 Human YIF1B Protein (AC1767) 5 µg inquiry ACPP-1279 NEDD4 Blocking Peptide (AC1279) 250 µg inquiry ACPP-1807 Human QKI Protein (AC1807) 2 µg inquiry ACPP-1066 Recombinant Human FGF2 Protein (Fc Tag) (AC1066) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket